•
Dec 31, 2020

REGENXBIO Q4 2020 Earnings Report

Total Revenue
$21.4M
Previous year: $11.8M
+82.2%
EPS
-$1.24
Previous year: -$0.72
+72.2%
Gross Profit
$11.2M
Previous year: $7.98M
+40.3%
Cash and Equivalents
$338M
Previous year: $69.5M
+386.8%
Free Cash Flow
$26.6M
Previous year: -$26.5M
-200.2%
Total Assets
$708M
Previous year: $498M
+42.2%

REGENXBIO

REGENXBIO